Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

AZN Astrazeneca PE ratio, current and historical analysis

The current PE ratio for Astrazeneca stock as of May 12, 2025 is 27.47. This is calculated based on the TTM EPS of $2.51 and the stock price of $68.95 per share. The PE ratio marks a decrease of 17% from its last 4 quarters average of 33.2.

AZN PE ratio history

How has AZN's PE ratio performed in the past

The average historical PE ratio of Astrazeneca for the last ten years is 81.35. The current P/E ratio of 27.47 is 66% lower than the historical average. Looking back at the last ten years, AZN's PE ratio peaked in the Dec 2021 quarter at 1,456.25, when the price was $58.25 and the EPS was $0.04. The lowest point was in the Dec 2016 quarter, when it reached 19.65 with a price of $27.32 and an EPS of $1.39.

Today
27.47
Average
81.35
Median
37.3
Minimum
19.65
Maximum
1,456.25

Astrazeneca PE ratio by year

Maximum annual increase: 3,453.56% in 2021

Maximum annual decrease: -95.61% in 2022

Year PE ratio PE change Price EPS
2024 28.86 -17.73% $65.52 $2.27
2023 35.08 -45.15% $67.35 $1.92
2022 63.96 -95.61% $67.8 $1.06
2021 1,456.25 3,453.56% $58.25 $0.04
2020 40.98 -57.26% $49.99 $1.22
2019 95.88 114.59% $49.86 $0.52
2018 44.68 53.22% $37.98 $0.85
2017 29.16 48.4% $34.7 $1.19
2016 19.65 -35.17% $27.32 $1.39
2015 30.31 -57.8% $33.95 $1.12
2014 71.82 146.8% $35.19 $0.49
2013 29.1 205.35% $29.69 $1.02
2012 9.53 50.32% $23.64 $2.48
2011 6.34 -23.15% $23.15 $3.65
2010 8.25 -8.64% $23.1 $2.8

Astrazeneca PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 29.28 1.46% $73.5 $2.51
Dec 2024 28.86 -22.21% $65.52 $2.27
Sep 2024 37.1 -1.07% $77.91 $2.1
Jun 2024 37.5 13.46% $77.99 $2.08
Mar 2024 33.05 -5.79% $67.75 $2.05
Dec 2023 35.08 -1.57% $67.35 $1.92
Sep 2023 35.64 -0.89% $67.72 $1.9
Jun 2023 35.96 -21.24% $71.57 $1.99
Mar 2023 45.66 -28.61% $69.41 $1.52
Dec 2022 63.96 -34.69% $67.8 $1.06
Sep 2022 97.93 N/A $54.84 $0.56
Jun 2022 N/A N/A $66.07 -$0.53
Mar 2022 N/A N/A $66.34 -$0.43
Dec 2021 1,456.25 1,476.03% $58.25 $0.04
Sep 2021 92.4 122.12% $60.06 $0.65

AZN average PE ratio chart

What is the average PE ratio of AZN for the past years

Currently, AZN's PE ratio is lower than its 3, 5 and 10-year averages.

3-year avg
43.64
5-year avg
125.9
10-year avg
81.35
15-year avg
61.34

AZN PE vs peers

What is AZN's PE ratio compared to its peers

In comparison to its peer LLY, AZN's PE ratio is lower, but it is higher than JNJ's and ABT's. Astrazeneca's PE ratio is trading above the peer average of 21.35.

Stock name PE ratio Market cap
MRK Merck & Co Inc 11.67 $201.96B
BIIB Biogen Inc 12.24 $18.23B
PFE Pfizer Inc 16.61 $131.28B
NVS Novartis AG 16.92 $213.47B
JNJ Johnson & Johnson 17.01 $370.87B
ABT Abbott Laboratories 17.1 $229.64B
BMY Bristol Myers Squibb Co 17.98 $98.05B
AZN Astrazeneca plc 27.47 $213.75B
LLY ELI LILLY & Co 61.23 $716.08B

Frequently asked questions

What is Astrazeneca's PE ratio?

AZN stock has a price to earnings ratio of 27.47 as of May 12, 2025.

What is the 3-year average PE ratio for Astrazeneca (AZN)?

The 3-year average price to earnings ratio for AZN stock is 43.64.

What is the 5-year average PE ratio for Astrazeneca (AZN)?

The 5-year average price to earnings ratio for AZN stock is 125.9.

What is the highest PE ratio for AZN?

Over the last ten years, the quarterly PE ratio reached its highest level at 1,456.25 in the Dec 2021 quarter.

How does the current PE ratio for AZN compare to its historical average?

The current PE ratio of AZN is 66% lower than the 10-year historical average.

How is AZN's PE ratio calculated (Astrazeneca PE ratio formula)?

You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 12, 2025), Astrazeneca's share price is $68.95. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $2.51. Therefore, Astrazeneca's PE ratio for today is 27.47. PE RATIO(27.47) = STOCK PRICE($68.95) / TTM EPS($2.51)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.